Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | AXL |
| Variant | Y821F |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | AXL Y821F lies within the protein kinase domain of the Axl protein (PMID: 31825826). Y821F demonstrates reduced binding to Abl2 in the presence of ligand in cell culture (PMID: 31825826), and therefore, is predicted to lead to a loss of Axl protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
AXL mutant AXL inact mut AXL Y821F |
| Transcript | NM_021913.5 |
| gDNA | chr19:g.41259681A>T |
| cDNA | c.2462A>T |
| Protein | p.Y821F |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001699.6 | chr19:g.41259708A>T | c.2462A>T | p.Y821F | RefSeq | GRCh38/hg38 |
| NM_021913.4 | chr19:g.41259681A>T | c.2462A>T | p.Y821F | RefSeq | GRCh38/hg38 |
| NM_021913.5 | chr19:g.41259681A>T | c.2462A>T | p.Y821F | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|